Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0130
+0.0010 (8.33%)
May 8, 2026, 4:10 PM AEST
Avecho Biotechnology Earnings Call Transcripts
Fiscal Year 2026
-
A proprietary CBD capsule for insomnia, enhanced with TPM technology, is in a pivotal phase III trial with interim results due in June. A major licensing deal with Sandoz secures Australian rights, with significant revenue potential and global expansion opportunities.